Pharmaceutical companies in Denmark by P/E ratio

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Novo Nordisk has the lowest figure of the 3 pharmaceutical companies in Denmark ranked by P/E ratio, at 9.8, followed by Ascendis Pharma (16.8) and Genmab (43.9). Figures as of 19 Nov 2026, 21:19 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
3
Lowest
Novo Nordisk9.8
Median
16.8
Combined market value
₩293.09T
Countries
1

Market values as of .

Denmark
All sectors
Pharmaceuticals
KRW
Clear filters
Pharmaceutical companies in Denmark by P/E ratio
#CompanyP/E ↑Market capPriceToday1 yearPrice, 30 daysCountry
1Novo NordiskNVO · Health Care9.8₩228.47T₩51,838.20 1.42% down 17% down Denmark
2Ascendis PharmaASND · Health Care16.8₩22.39T₩341,355.93 5.32% down 29% up Denmark
3GenmabGMAB · Health Care43.9₩42.23T₩68,481.90 0.75% up 70% up Denmark

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1333.6 KRW).

Questions and answers

Which pharmaceutical companies in Denmark have the lowest P/E ratio?

Novo Nordisk (9.8), Ascendis Pharma (16.8) and Genmab (43.9) have the lowest P/E ratio of the 3 pharmaceutical companies in Denmark ranked here as of 19 Nov 2026, 21:19 UTC.

How many pharmaceutical companies in Denmark are in this ranking?

3 are ranked by P/E ratio.

What are these pharmaceutical companies in Denmark worth together?

The 3 pharmaceutical companies in Denmark ranked by P/E ratio have a combined market value of ₩293.09T as of 19 Nov 2026, 21:19 UTC.

What does ranking by P/E ratio measure?

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Cite this page

Funkfolio, “Pharmaceutical companies in Denmark by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=denmark&by=pe-ratio

Underlying data: Yahoo Finance; SEC EDGAR.